Their study further demonstrated that POLCs serve as a negative prognostic marker for prostate cancer bone metastasis, with PTX3 playing a significant role in the metastatic process, analogous to its involvement in breast cancer bone metastasis (79). The gene discussed is PTX3; the disease is breast cancer.